News

Alpha-gal syndrome is not your typical food allergy, according to Scott P. Commins, MD, PhD, who spoke exclusively to Healio at the American Academy of Allergy, Asthma & Immunology Annual Meeting. Alpha-gal syndrome is caused by a bite from the…

Multiple challenges faced by people with food allergies when travelling by air have been highlighted by a large, multi-national survey of airline passengers. Conducted by the Centre for Food Allergy & Asthma Research, Northwestern University Feinberg School of Medicine, the…

Early lab trials using a new research-based treatment for the prevention of peanut allergy are showing the potential for it to be an effective preventative for peanut-specific allergic responses. The new treatment, referred to as ‘Covalent heterobivalent inhibitor’ (cHBI), works…

People with coeliac disease have been found to have a higher chance of having heart disease compared to those without coeliac disease. The findings come from a study using data from the UK Biobank, a large database of health information,…

The prevalence of allergic diseases in the Middle East Region is said to be rapidly increasing, while food allergy knowledge in the population is lacking. Recent studies have delved deeper into prevalence and knowledge of food allergies in Saudi Arabia.…

Aravax is a Melbourne-based biotechnology company developing the first precisely targeted immunotherapeutic for peanut allergy, PVX108. An investment of US$20m from Australian investors, Brandon Capital and Tenmile will support Phase 2 trials. PVX108 does not contain peanut protein but is…